Difference between revisions of "Spebrutinib (CC-292)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
m |
||
(6 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
− | =Mechanism of action= | + | ==Mechanism of action== |
Bruton's tyrosine kinase (BTK) inhibitor | Bruton's tyrosine kinase (BTK) inhibitor | ||
+ | |||
+ | ==Also known as== | ||
+ | *'''Code names:''' AVL-292, CC-292 | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
− | [[Category: | + | [[Category:Oral medications]] |
− | |||
[[Category:BTK inhibitors]] | [[Category:BTK inhibitors]] | ||
− | [[Category:Investigational]] | + | [[Category:Investigational drugs]] |
Latest revision as of 23:32, 23 February 2021
Mechanism of action
Bruton's tyrosine kinase (BTK) inhibitor
Also known as
- Code names: AVL-292, CC-292